Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...
The technology sector is no longer asking what artificial intelligence can do for us. It is asking what AI can do for itself.
OpenAI is rolling out an early version of an artificial intelligence model designed to accelerate drug discovery, joining a ...
SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal ...
3dOpinion
AI needs a reality check
Marketing claims in AI rarely survive contact with reality. That’s because making real progress in healthcare is hard. To ...
Morning Overview on MSN
Amazon launches Bio Discovery AI tool for drug research
Amazon has reportedly developed an artificial intelligence platform called Bio Discovery, designed to help drug researchers ...
The model will be available initially as a research preview to some of the company’s business customers, OpenAI said ...
Three Vectors of Urban Transformation,” published in Applied Sciences, explores how cities are entering a new phase of technological evolution driven by the convergence of agentic artificial ...
Meta's new hyperagent framework breaks the AI "maintenance wall," allowing systems to autonomously rewrite their own logic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results